Clinical trial · Interventional
Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer
Using Digital Phenotyping to Optimize Psychosocial Risk Screening and Personalized Care: a Pilot Study in Adolescents and Young Adults With Cancer
NCT07220343CI-TRIAL-00099883recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The overall goal of the proposed study is to use digital phenotyping to identify and triage at-risk patients and accelerate access to critical mental health services.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adolescents | — | UNRESOLVED | — |
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Device | Device | — | UNRESOLVED |
| Ecological Momentary Assessment (EMA) via My Personal Health Dashboard (MyPHD) Smartphone App | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Digital Phenotyping Arm
- description
- All participants (adolescents and young adults with cancer) will receive the digital phenotyping intervention, which includes wearing a smartwatch and using a smartphone-based EMA app over a 10-day period, with psychosocial assessments at baseline, day 10, and 2 months
- interventionNames
- Device: Device
- Behavioral: Ecological Momentary Assessment (EMA) via My Personal Health Dashboard (MyPHD) Smartphone App
Primary outcomes (1)
- measure
- Change in Depressive Symptoms (Beck Depression Inventory - BDI)
- timeFrame
- Baseline, Day 10, 2 months
- description
- The Beck Depression Inventory-II (BDI-II; range 0-63) will be used to measure changes in depressive symptoms among adolescents and young adults over time. Higher scores indicate greater depressive symptom severity.
Secondary outcomes (7)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 10 Years
- Maximum age
- 25 Years
Show eligibility criteria text
Inclusion Criteria: * 10-25 years old * Recent cancer diagnosis (\>2 and \<18 months since diagnosis) * Willing to carry smartphone on their person for duration of study participation * Willing to wear smartwatch for duration of study participation Exclusion Criteria: * Significant physical or mental disability that prevents completion of study activities * Lack of proficiency in English or Spanish
References
Publications (0)
Data not yet available
No reference posted for this study.